Device for shunting blood between the arterial and venous systems

Information

  • Patent Grant
  • 12070542
  • Patent Number
    12,070,542
  • Date Filed
    Thursday, March 24, 2022
    2 years ago
  • Date Issued
    Tuesday, August 27, 2024
    3 months ago
Abstract
A shunting system includes a housing through which blood flow is regulated when passing therethrough, for example, from the arterial side to the venous side of the circulatory system. The housing is easily separable into housing components, the separability providing for access to inner components including a blood filter, which is easily removable from a connector disc, the blood filter and connector disc held in place in the housing when the housing components are coupled.
Description
TECHNICAL FIELD

The present disclosure relates generally to body fluid transferring apparatus, and particularly to shunts and shunting devices and methods for their use in transferring blood from the arterial system to the venous system of a patient.


BACKGROUND OF THE DISCLOSURE

Contemporary devices for bodily fluid transfer, including blood, include shunts. In the case of blood, shunts typically serve to transfer blood from the arterial system to the venous system of a patient.


SUMMARY OF THE DISCLOSURE

The disclosed devices and systems provide for shunting blood from the arterial to the venous side of a patient's circulatory system, allowing clinicians to perform operations, while minimizing the obstruction or impedance of blood flow, without impairing the patient's health. For example, the disclosed devices and system are used to assist in the treatment of medical conditions in humans or animals, for example, insertion of a stent into the carotid artery and other, endarterectomy, and neurovascular procedures.


The disclosed devices and systems include a two component housing—a first housing component or trigger housing, for component receiving arterial side tubing (also known as arterial tubing), which connects to an artery of the patient, and, a second housing component, which serves as a blood reservoir for receiving the blood which passed through the first housing component. The second housing component and holds the blood, in order to stabilize delivery pressure of the blood, prior to the blood leaving the reservoir through venous side tubing (also known as venous tubing), through which blood returns to the circulatory system through a vein.


The arterial side tubing extends through the first housing component. An adjustable trigger, also known as a regulator, extends into the first housing component and contacts the arterial tubing, depressing the arterial tubing at various depths, to control the shape (e.g., diameter) of the lumen of the arterial tubing, and therefore, adjust the rate of blood flow (regulate the rate of blood flow) through the arterial tubing. A second housing component, or reservoir housing, joins to the first housing component, and includes a reservoir, for the blood entering from the arterial side tubing. Venous side tubing extends from the second housing component, through which blood flows from the reservoir to the vein of the patient.


A blood filter extends into the reservoir and aligns with the arterial tubing, such that all blood entering the reservoir is subjected to filtration. The filter is easily accessible and removable from the device (housing), as it is held by a snap fit by a connector disc, which serves as a capture mechanism or holder for the filter. The connector disc is in turn, held in place in the first housing component by a compression or press fit with the second housing component, when the second housing component is joined to the first housing component. The first and second housing components are easily separable from each other as they are joined by a friction fit, for example, a press fit, such that a portion of the proximal end of the second housing component is received in a portion of the distal end of the first housing component by a friction fit including a press fit. A connector ring maintains the press fit of the second housing component in the first housing component (and also prevents the second housing component from moving distally) and attaches to the first housing component by a frictional engagement, including a threaded engagement with the first housing component.


Embodiments of the disclosure are directed to a shunt. The shunt comprises: a first housing configured for receiving a first conduit for blood ingress, the first conduit for extending in the first housing; a regulator extending into the first housing for communicating with the first conduit to control blood flow rate through the first conduit; and, a second housing removably attachable from the first housing, the second housing comprising a cavity for receiving and holding blood from the first conduit, and configured for receiving a second conduit, such that the second conduit is in communication with the cavity for blood egress through the second conduit.


Optionally, the shunt is such that it additionally comprises: a blood filter extending at least partially into the cavity of the second housing, the blood filter in the second housing for communication with the first conduit in the first housing.


Optionally, the shunt is such that it additionally comprises: a connector, for example, a connector ring, for joining the first housing to the second housing so that the second housing is removably attachable from the first housing.


Optionally, the shunt is such that the first housing and the connector form a threaded connection, such that the first housing and second housing are removably attachable from each other.


Optionally, the shunt is such that the regulator is adjustable between a plurality of positions, each position corresponding to a rate of blood flow through the first conduit.


Optionally, the shunt is such that the regulator includes a trigger lever, the trigger lever being movably mounted in the first housing.


Optionally, the shunt is such that it additionally comprises the first conduit extending through the first housing for blood ingress into the first housing.


Optionally, the shunt is such that it additionally comprises a second conduit in communication with the cavity for blood egress from the cavity of the second housing.


Optionally, the shunt is such that it additionally comprises a connector disc for seating in the first housing, the connector disc including oppositely disposed first and second sides, and including an aperture extending between the first and second sides, the connector disc for connecting with the first conduit one the first side, and the blood filter on the second side, whereby the first conduit communicates with the blood filter via the aperture to form a path for blood flow through the shunt.


Optionally, the shunt is such that the connector disc includes a conduit connector extending from the first side in line with the aperture, for connecting with the first conduit in at least a friction fit, and, a plurality of outwardly extending and circumferentially arranged fingers about the aperture, such that the fingers for receiving the blood filter in at least a snap fit, whereby the first conduit, the conduit connector, the aperture and the blood filter are aligned to form the path for blood flow through the shunt.


Optionally, the shunt is such that it additionally comprises a plurality of protrusions extending into an inner cavity of the first housing for receiving the connector disc to seat in the first housing, and when the first housing is removably attached to the second housing, the connector disc in held in the first housing by a press fit between the plurality of protrusions and a portion of the second housing which extends into the first housing.


Embodiments of the disclosure are directed to a method for assembling a medical device. The method comprises: providing a shunt comprising: a first housing configured for receiving a first conduit for blood ingress; a regulator extending into the first housing for communicating with the first conduit to control blood flow rate through the first conduit; and, a second housing removably attachable from the first housing, the second housing comprising a cavity for receiving and holding blood from the first conduit, and configured for receiving a second conduit. The first conduit is attached (e.g., joined or coupled) to the shunt at the first housing; and, a second conduit is attached (e.g., joined or coupled) to the shunt at the second housing; whereby the first conduit and the second conduit are in communication with each other via the shunt.


Embodiments of the disclosure are directed to a method for blood transfer in a mammalian patient. The method comprises: providing a shunt comprising: a first housing configured for receiving a first conduit for blood ingress; a regulator extending into the first housing for communicating with the first conduit to control blood flow rate through the first conduit; and, a second housing removably attachable from the first housing, the second housing comprising a cavity for receiving and holding blood from the first conduit, and configured for receiving a second conduit. A first conduit is attached to the shunt at the first housing, and a second conduit is attached to the shunt at the second housing. The first conduit is placed in communication with the mammalian patient at a first location on the mammalian patient; and, the second conduit is placed in communication with the mammalian patient at a second location on the mammalian patent; such that a blood flow pathway is established between the first conduit and the second conduit, via the shunt.


Optionally, the method is such that the first location comprises an arterial portion of a circulatory system of the mammalian patient, and the second location comprises a venous portion of the circulatory system of the mammalian patient, and the blood flow pathway is from the first conduit to the second conduit, via the shunt.


Optionally, the method additionally comprises: regulating the blood flow along the blood flow pathway by placing the regulator into contact with the first conduit at a location along the first conduit and depressing the regulator to cause the first conduit to decrease in size proximate to the location.


Optionally, the method is such that it additionally comprises: regulating the blood flow along the blood flow pathway by releasing the regulator from the depressing contact with the first conduit at the location along the first conduit, to cause the first conduit to increase in size proximate to the location.





BRIEF DESCRIPTION OF THE DRAWINGS

Non-limiting examples of embodiments are described below with reference to figures attached hereto that are listed following this paragraph. Identical structures, elements or parts that appear in more than one figure are generally labeled with a same numeral or character in all the figures in which they appear. Dimensions of components and features shown in the figures are chosen for convenience and clarity of presentation and are not necessarily shown to scale.


In the drawings:



FIG. 1 is an illustrative view of a shunting system, in accordance with an embodiment of the present disclosure;



FIGS. 2A-2C are exploded views of the shunting system of FIG. 1;



FIG. 3 is a perspective view of a connector disc of the shunting system in accordance with an embodiment of the disclosure;



FIG. 4 is a perspective view of the first housing of the shunt of FIG. 1;



FIG. 5 is a cross-sectional view of the first housing of FIG. 1;



FIG. 6 is a perspective view of the second housing of FIG. 1;



FIG. 7A is a side view of the trigger lever of the shunting system of FIG. 1;



FIG. 7B is a perspective view of the trigger lever of the shunting system of FIG. 1;



FIG. 8A is a cut-away side view of the blood flow pathway of the shunting system of FIG. 1;



FIG. 8B is a cross sectional view of FIG. 8A;



FIGS. 9A, 9B and 9D are cut-away sectional views of the first housing in accordance with an embodiment of the disclosure; and



FIG. 9C is a cross sectional view taken along line 9C-9C of FIG. 9B.





DETAILED DESCRIPTION OF EMBODIMENTS
Overview

The shunting of blood by systems which transfer blood from the arterial system to the venous system is typically achieved using the differential pressure between the patient's (e.g., a mammalian patient) arterial and venous circulatory systems. However, sometimes when unimpeded flow is established between the two systems at two vessel entry points, for example, between the carotid artery and the femoral vein, the flow can overwhelm the body's ability to achieve homeostasis in the neuro-vascular system leading to complications during procedures. The present disclosure provides a shunting system or shunt, that compensates for the differential pressure and controls rapid blood flow (e.g., rapid blood flow rate) into a blood reservoir of the device, allowing blood to flow into the venous system, at a rate where homeostasis is maintained.


The present disclosure provides apparatus and systems that temporarily reduce blood flow, e.g., blood flow rate and/or pressure, through a shunting system, from which blood is transferred from the arterial side to the venous side of a patient's circulatory system. This temporary reduction of blood flow rate in the shunting system reduces the risk of coagulation and clogging of fluid pathways.


The present disclosure provides a shunting system, including a device comprising a housing through which blood flow is regulated when passing therethrough, for example, from the arterial side to the venous side of the circulatory system. The housing is easily separable into housing components, the separability providing for access to inner components including a blood filter, which is easily removable from a connector disc, the blood filter and connector disc held in place in the housing when the housing components are coupled.


The device includes a first housing component, or trigger housing, which mechanically couples to a second housing component, or reservoir housing. The trigger in the trigger housing allows for manual operation of a trigger, which when in operation, controls the rate of blood flow through the trigger housing (and downstream through the reservoir housing and venous side tubing).


The trigger housing may include an adjustable trigger (also known as a regulator), which may be manually controlled, for reducing flow through the housing, as well as an entry portal allowing for the acceptance of arterial side tubing. The trigger housing may have an exit portal to which the distal end of the arterial side tubing (through which blood enters from an arterial access point) may be attached. The reservoir housing includes an internal cavity which serves as a blood reservoir, and receives blood from the arterial side tubing in the trigger housing, through an inflow portal. The blood reservoir also includes and outflow portal, to which venous side tubing is attached, so that the arterial side blood reenters the body therethrough the venous side of the circulatory system. A blood filter extends through the blood reservoir and receives the blood from the inflow portal. The blood filter catches particles including plaque or other debris that may be produced by interventional or other medical procedures, as the shunted blood flows through the filter along its path to the venous side tubing and into the venous system through a venous access point.


The two housing components are mechanically connected by a connector ring, which joins the first and second housing components, and holds them together. The first and second housing components are such that they are joined mechanically by a friction fit, for example, a press fit, such that a portion of the proximal end of the second housing component is received in a portion of the distal end of the first housing component by a friction fit including a press fit. A connector ring maintains the press fit of the second housing component in the first housing component (and also prevents the second housing component from moving distally) and attaches to the first housing component by a frictional engagement, including a threaded engagement with the first housing component. The blood filter is held in the housing by this mechanical connection, as the second housing component press fits the connector ring, against protrusions in the first housing component. The connector ring snap fits to the blood filter. The blood filter extends at least partially into the blood reservoir. The snap fit renders the blood filter easily and quickly accessible and removable (separable) from the connector disc. Both the snap fit of the blood filter to the connector disc, and the press fit of the connector disc by the joined housing components (e.g., sections), as well as the joined housing components, typically do not employ any glues, adhesives, welds, tapes, mechanicals, fasteners, such as screws, nails, rivets. As a result, the housing is easily disassembled, and the connector disc, and the blood filter held thereby, are easily accessible and removable from the device, and easily separable from each other. Moreover, the disclosed device 100a and system 100 may be subsequently reassembled to the original configuration, absent any additional fasteners and/or fastening procedures.


The aforementioned mechanical friction fits, for example, snap fits press fits, compression fits, threaded engagements, hold the device and its components together, in a manner such that the holding forces are sufficient to maintain the housing and components therein in mechanically secure engagements, such that any adhesives or fastening techniques, such as gluing or welding, screws, rivets, clips, or the like, are not necessary. This engagement of system components reduces risks of component failure in the system, and making it simple for the user to open the system (e.g., the housing of the system) to inspect and/or remove the blood filter as desired.


For example, the blood filter is easily removable from the housing in an intact manner, allowing for rapid examination of particles in the filter by the clinician. This structure of the disclosed housing avoids problems with blood filters, that are welded and/or glued to housing components, or other internal components used within the housing components, and as such, are prone to mechanical failure. This is because the connector disc and/or the blood filter may dislodge, and impede blood flow during a procedure, which has potentially fatal consequences to the patient.


In some embodiments the system includes a trigger housing with a trigger, that may quickly and easily reduce or regulate blood flow through the system. The trigger housing typically has an input portal that allows acceptance of tubing that may be attached to an arterial vessel access point.


In other embodiments, the trigger housing includes a blood reservoir housing which may have a portal to which venous side tubing is attached, allowing blood to exit from the blood reservoir to a venous access point. The system, for example, includes arterial side tubing, which extends into the trigger housing and communicates with an entry portal or opening of the blood reservoir. The blood reservoir typically has an exit portal to which venous side tubing connects, which in turn, typically attaches to a venous access point.


The trigger housing, for example, contains a trigger lever with a button, which can be depressed in order to cause the trigger lever to engage with, and depress the arterial side tubing that is secured within the trigger housing, thus allowing for temporary reduction of blood flow into the blood reservoir. The trigger lever is also releasable, and coupled with the resilience of the arterial side tubing, disengages in a spring-like manner, to increase blood flow into the blood reservoir, as the arterial side tubing adjusts to widen the lumen size, with the lumen returning to its original size once all pressure is released from the trigger lever.


System Description

Throughout this document, references to directions and orientations, such as proximal, distal, inner outer, longitudinal, transverse, inward, outward, inner, outer, upper, lower, front, rear, top, bottom, lateral, upstream, downstream, and derivatives thereof, and the like. The references to these directions and orientations are exemplary, for describing and explaining the present disclosure, and embodiments thereof, and are not limiting in any way.



FIG. 1 illustrates a system 100 which allows shunting of blood from the arterial to the venous side of a patient's circulatory system. The system 100 includes a shunt 100a (also known as a device, these terms used interchangeably herein), with a proximal end 100ap and a distal end 100ad, through which a longitudinal axis LA extends. The longitudinal axis LA extends from a proximal end PE to a distal end DE, these “proximal” and “distal” end orientations used herein for reference purposes when describing the system 100 and the components thereof.


The shunt 100a, at the proximal end 100ap, attaches to arterial side tubing 101, and at the distal end 100ad of the shunt 100a, to venous side tubing 102. The shunt 100a includes a housing 100a′ (or body, these terms used interchangeably herein), formed, for example, of two connectable housing components. These components include a first housing component or trigger housing 103, which attaches to a second housing component or reservoir housing 105 (or blood reservoir), as a connector ring 104 of the reservoir housing 105 threadably engages or screws onto a correspondingly threaded 124 flange 125 (FIGS. 2A-2C) on the outer surface of the trigger housing 103. The system 100 is such that blood is carried from an arterial entry point, or starting point, through the device 100a (from the first housing (component) 103 to the second housing (component) 105), to a venous entry point, or finish point, this direction of travel for the blood flow known as “downstream”. For example, the trigger housing 103, the connector ring 104, and the reservoir housing 105 are symmetric along the longitudinal axis LA.


The arterial-side tubing 101 attaches to the patient's arterial entry point (not shown), for blood ingress into the system 100. This tubing 101 fits into entry portal 110 of the trigger housing 103 (e.g., joining or coupling to the trigger housing 103), for example, by a frictional engagement. Venous side tubing 102 attaches to the patient's venous entry point (not shown), for blood egress from the system 100. The tubing 102 also attaches (e.g., joins or is coupled to) to the exit portal 111 of the blood reservoir 105, for example, by a frictional engagement over the exit portal 111.


The trigger housing 103 includes an entry portal 110 extending outward and allowing a distal end of the arterial side tubing 101 to be fitted and passed into the trigger housing 103, so as to extend therethrough, until connecting to a port, formed by a protuberance 141, extending proximally from a connector disc 117 (FIGS. 2A-2C), inside the trigger housing 103.


A trigger lever 126 (shown in greater detail in FIGS. 2A-2C, 7A and 7B), also known as a regulator, includes a button 107 and an engagement arm 108, from which extends an outwardly protruding tab 109. The trigger lever 126 extends out of a slot 120, which is formed in trigger housing 103, at, for example, the upper side (upper portion). The remainder of the trigger level button 107 is in the inner cavity 118 of the trigger housing 103. A trigger lever pin 106, disposed on each of opposite arms 106a of the trigger level button 107, extends out of oppositely disposed mount holes 112 (only one shown) in the trigger housing 103, such that the trigger lever 126 is pivotally (rotationally) mounted on the trigger housing 103. This pivotal mounting allows the trigger lever 126 to be moved or depressed, for example, manually, to various positions inside and outside of the trigger housing 103, the positions of the trigger lever 126 for regulating blood flow through the trigger housing 103 and downstream therefrom.


Turning also to FIGS. 2A-2C, there are shown exploded views of the system 100. The trigger housing 103 includes an entry portal 110, a slot 120 in the upper proximal surface, and an inner cavity 118. The trigger housing 103 terminates in a distal rim 103x at the distal edge 103x′ of the housing 103. The threaded flange 125 extends proximally, from the distal edge 103x′ to a ring stop 122, which is of a larger diameter than the connector ring 104, to serve as a travel limit for proximal movement of the connector ring 104, when the trigger housing 103 and the blood reservoir 105 are joined together.


The arterial side tubing 101 extends into the entry portal 110 of the trigger housing 103, where it connects to a protuberance 141 of the connector disc 117 (shown in detail in FIGS. 8A and 8B). The protuberance 141 includes an outer surface 140 that slopes distally upward and away from its proximal edge. The connection is such that the arterial side tubing 101 inner walls 101a typically engage the protuberance 141 by extending over a circumferential ledge 140a, to form a secure attachment, as shown in FIG. 8B.


The arterial side tubing 101 is received in an acceptance channel 184 along surfaces 110a which are formed on the bottom or lower side of the inner cavity 118 of the trigger housing 103, as shown in FIG. 5. The surfaces 110a are shaped to fit snugly around the bottom and sides of the outside diameter of a portion of the arterial side tubing 101, to hold the arterial side tubing 101 in place. For example, the sides and bottom of the distal bottom surface 110a of acceptance channel 184 of the trigger housing 103 are round, such as in a tube shape, so as to form the acceptance channel 184. The acceptance channel 184 surfaces 110a, for example, mirror the shape of the arterial side tubing 101, while snugly fitting the arterial side tubing 101, for example, along an arc of approximately between 120 degrees to 270 degrees (e.g., leaving the top circumference of the arterial side tubing 101 not in contact with the acceptance channel surface 184).


Moving distally (toward the distal end DE) along the longitudinal axis LA, a connector disc 117, for seating in the trigger housing 103, is shown in detail in FIG. 3. The connector disc 117, is, for example, circular in cross section, so as to fit within the inner cavity 118 of the trigger housing 103, by seating against protrusions 180 extending inward into the cavity 118. The connector disc 117 includes an internal base or plate 117a, and an outer cylinder 117b, which, for example, is tapered outward proximally (toward the proximal end PE of the longitudinal axis LA) to an outer platform 117c. The outer platform 117c, along its circumferential edge 150, includes, for example, two first segments 150a between second 150b segments, the first 150a and second 150b segments extending along arc lengths at different elevations. The first segments 150a are formed by grooves which terminate at longitudinally extending surfaces 150a′, along the circumferential edge 150.


Turning also to FIGS. 4 and 5, the first segments 150a receive and contact protrusions 180, which are in sets, with the protrusions of each set at the same elevation (extending into the cavity 118 to the same distance). The protrusion 180 sets are arranged to extend along an arc length, which is slightly less that the arc length (span) of the grooves, which form the first segments 150a, to fit within the respective groove of each first segment 150a. There is an open area 181 between each protrusion set. For example, the protrusion sets are oppositely disposed from each other, as are the open areas 181 between the protraction sets.


The protrusions 180, for example, are formed in sets and extend circumferentially around the inner distal surface 118, proximate to the location of the flange 125 on the trigger housing 103. The protrusions 180 are sized to capture and mate with the first segments 150a of the connector disc 117. For example, the protrusions 180 are rectilinear in shape, and, for example, knife shaped. There are, for example, two sets of protrusions, extending an arc length just slightly less than the corresponding arc length of the respective first segment 150a (e.g., groove thereof).


The end protrusions 180x of each protrusion set are positioned to abut or be in close proximity to the longitudinally extending faces 150a′ of each first segment 150a, so as to fit within the grooves of the first segments 150a. The end protrusions 180x serve as stop surfaces or rotational travel limits, to prevent the connector disc 117 for moving rotationally, such that the connector disc 117 seats in the inner cavity 118 of the trigger housing 103 perpendicular or substantially perpendicular to the longitudinal axis LA. While two protrusion sets with two open areas 181 are shown, any number of protrusion sets with corresponding open areas are permissible, provided there are grooves in first segments 150a to accommodate the protrusions 180, so that the connector disc 117 seats on the protrusions 180 substantially free of rotation and perpendicular or substantially perpendicular to the longitudinal axis in the trigger housing 103.


Moving back to FIGS. 2B, 2C and 3, the connector disc 117 is such that the protuberance 141 extends proximally from the proximal side 117p of the base 117a of the connector disc 117. The protuberance 141 extends, for example, through the open area 181 between the sets of protrusions 180. In the base 117a, there is an aperture 129, extending through the base 117a, which communicates with the lumen 142 (FIGS. 8A and 8B) of the protuberance 141, and aligns with the opening 113a in the housing ring 113 at the proximal portion of the blood filter 115, so as to create a blood flow pathway between the trigger housing 103 and the blood reservoir 105, as shown in detail in FIGS. 8A and 8B.


The distal side 117d of the connector disc 117 includes circumferentially spaced fingers 130 formed and extending outward from its distal surface with indents 131 formed in the fingers 130. The indents 131 provide additional friction or holding force for the respective fingers 130. The fingers 130, for example, extend distally from the connector disc 117 in an inward slope or taper, such that the proximal portion of the fingers 130 is of a slightly greater diameter than the housing ring 113 of the blood filter, while the distal ends of the fingers are of a diameter slightly less than the outer diameter a housing ring 113 of the blood filter 115. This smaller diameter formed by the fingers 130 at their distal ends serves to secure the blood filter 115 in the connector disc 117 (e.g., in abutment or close proximity with the base 117a), in an interference press fit. As the fingers 130 are of a resilient material, they behave in a spring-like manner, to frictionally engage and retain the blood filter 115 in the aforementioned interference press fit, by via the housing ring 113.


The blood filter 115 housing ring 113, includes an opening 113a. A lateral “U” shaped stabilizer 114, extends (e.g., distally) from the housing ring 113. The U-shaped stabilizer 114 supports filter weave material 115a. The blood filter 115 extends to a length suitable to allow the blood filter 115 to seat in the correspondingly shaped inner cavity 165 (FIG. 6) of the blood reservoir 105.


The filter weave material 115a, for example, is a cross-woven monofilament made of hemo-compatible materials such as nylon or polypropylene. The material 115a is suitable for capturing particles of, for example, approximately 100 microns or greater. Other suitable filter weave materials capture particles, for example, of approximately 200 microns or greater in size, while still other filter weave materials capture particles, for example, of approximately of 300 microns or greater. The filter weave material 115 may be attached around the inner circumference of the housing ring 113 and attached to the stabilizer 114, forming a tube through which fluid or blood moving through the system 100 (e.g. downstream, entering the filter 115 at the housing ring 113 opening 113x) and traveling through the filter 115 to the blood reservoir 105.


Turning also to FIG. 6, the blood reservoir 105 tapers outwardly in the proximal direction, to an outwardly protruding ring 160, also known as a stop ring. The stop ring 160 is of a diameter equal to that of the rim 103x of the trigger housing 103, so as to serve as a travel limit (e.g., stop surface) for the reservoir housing 105, when the reservoir housing is joined to the trigger housing 103 (via the connector ring 104). A collar 161, extending proximally from the stop ring 160, and ending in a proximal edge 164, is of a diameter less than the stop ring 160. This dimensioning allows the collar 161 to fit between the outer cylinder 117b of the connector ring 117 and the inner wall 118a of the inner cavity 118 of the trigger housing 103, when the trigger housing 103 and the blood reservoir 105 are joined together to form the housing 100a′ for the shunt 100a. The edge 164 of the collar 161 abuts or is in close proximity to the platform 117c of the connector disc 117.


An exit portal 111 extends from the reservoir housing 105, and is open to the inner cavity 165 of the reservoir housing 105 via proximally extending finger tubes 162, which are formed on the inside surface of the distal end of blood reservoir 105 around a hole 162a. The holes 162a lead into an exit portal 111. The exit portal 111 is shaped to receive and hold venous side tubing 102.


The connector ring 104 is designed to be moved over the reservoir housing 105, so that the connector ring inner side 135 is received on the threaded flange 125 of the trigger housing 103, when the trigger housing 103 and reservoir housing 105 are engaged together. The inner side 135, along its surface, of the connector ring 104, is correspondingly threaded with respect to the threaded flange 125, for creating a mechanically secure frictional connection. The connector ring 104 has indents 136, which provide the user a gripping surface. The connector ring 104 has its travel in the proximal direction limited by the ring stop 122, which extends circumferentially around the trigger housing 103 to a diameter greater than that of the outer diameter of the connector ring 104.


The connector ring 104 has inside diameter “V” which is larger than diameter “T” of stop ring 160 so that its proximal edge 136a will fit over the stop ring 160. Distances “R” and “T” are, for example, approximately equal, where “T” is the outside diameter of the stop ring 160 and “R” is the inside diameter of connector ring 104. For example, the proximal end 136a of connector ring 104 is of sized to include sections of various diameters, which are wide enough for the connector ring 104 to slide over the stop ring 160 (e.g., when the connector ring 104 is moving proximally). The distal end 136b is sized to fit flush and engage with the ring stop 122.



FIGS. 7A and 7B show the trigger lever 126 in detail. The trigger lever 126 is, for example, a unitary member, formed of a resilient material such as a polymer, for example, by techniques such as injection molding. The trigger lever 126 includes a button 107, which is a main portion or body for the trigger lever 126. The trigger lever 126 and button 107 are, for example, symmetric about a longitudinal axis LA′. This trigger lever longitudinal axis LA′ is, for example, parallel to and coplanar with the Longitudinal axis LA of the device 100a.


The trigger lever 126 includes an engagement arm 108 with a tab 109 formed into its proximal surface, “U” shaped protrusion 128, and engagement pins 106, formed on arms 106a in each of its distal sides. The tab 109 protrudes from the arm 108 along a proximal surface 109a, and is outwardly tapered in the upward direction, along a surface 109b. The arm 108 is such that the resilient material provides it with spring-like behavior. Accordingly, the arm 108 can be moved or otherwise flexed or pushed inward (e.g., distally) to disengage the tab 109, along the surface 109a, from abutment with the shoulder 120x (FIG. 5) of the slot 120 of the trigger housing 103.


Additionally, when the arm 108 is moved downward, the arm 108 will move inward, as the tab 109, along its outer surface 109b, slides along the shoulder 120x of the slot 120, with the arm 108 snapping back (moving proximally) into place, once the tab 109 has moved sufficiently downward to clear the shoulder 120x of the slot 120 (such that upward movement of the trigger lever 126 is restricted). The resilient material also allows the pins 106 to be snapped into and out of the mount holes 112 of the trigger housing 103.


The U-shaped protuberance 128, at the lower portion of the trigger lever 126 is used to apply varying amounts of pressure (typically manually applied) to the arterial tubing 101, inside of the trigger housing 103, to change the dimensions of the lumen 101c of the arterial tubing 101 (e.g., decreasing the diameter of the tubing 101), for example, including deforming the lumen 101c to a smaller size, to regulate blood flow therethrough (and accordingly, downstream, into the blood filter 115, the reservoir 105, and ultimately, through the venous side tubing 102). For example, the “U” shaped protrusion 128 is formed to have a lower surface width “Q” where “Q” is 100% to 40% of the width of the arterial side tubing 101.


The trigger housing 103, connector ring 104, blood reservoir 105, blood filter ring 113 and lateral stabilizer 114, and connector disc 117, of the system 100, may be formed, molded or made of suitable materials such as a hard polycarbonate or other suitable plastic. These components are typically formed as unitary members (and optionally with the blood filter ring 113 and stabilizer 114 formed separately and joined together by adhesives and/or welds) by processes such as injection molding and other polymer molding techniques. The components, including the blood filter 115 and trigger lever 126, are fitted with one or more types of friction fits including, for example, snap fits press fits, and/or compression fits, which eliminate the need for gluing or welding, reducing risk of component failure in the system, and making it simple for the user to open the system to inspect or remove the blood filter as desired. The aforementioned components, for example, may be colored, painted, clear or opaque or a combination of these finishes.


Also, for example, the arterial 101 and venous 102 side tubing may be made of a flexible polymer material such as Tygon Medical/Surgical Tubing S-50-HL, attached to phlebotomy needles to access the respective arteries and veins.


System Operation


FIGS. 8A and 8B are diagrams detailing blood flow from the arterial tubing 101 (in the trigger housing 103), through the connector disc 117, and into the blood filter 115 (in the blood reservoir 105).



FIG. 8A shows the connections between the connector disc 117 and the arterial side tubing 101 on the proximal side of the connector disc 117, and the blood filter 115 on the distal side of the connector disc 117. The aperture 129 in the base 117a of the connector disc 117 aligns with the lumen 142 of the protuberance 141 and the inner lumen 101c of the arterial side tubing 101. Fluid (e.g., blood) flow AA is shown moving through the inner lumen 101c of the arterial side tubing 101, through the aperture 129 in connector disc 117, and then through the opening 113a of the housing ring 113 of the blood filter 115, prior to flowing downstream, into the blood reservoir 105 (e.g., the inner cavity 165 of blood reservoir 105).



FIG. 8B is a cross-sectional view of FIG. 8A. Fluid or blood flow “AA” is shown moving downstream, through the inner lumen 101c of the arterial side tubing 101, into the lumen 142 of the protuberance 141, and then through the aperture 129 in the base 117a of the connector disc 117. Blood then flows downstream, through the housing ring 113 of the blood filter 115, and through the filter mesh 115a of the blood filter 115, and into the blood reservoir 105. The blood flow out of the blood reservoir 105 is through the exit portal 111 (to which is attached venous side tubing 102, through which the blood is returned to the circulatory system through the venous system.



FIGS. 9A-9D show operation of the trigger lever 126 on the arterial tubing 101, which has been received in the trigger housing 103, to control blood flow (e.g., blood flow rate), through the arterial tubing 101 and downstream of the arterial tubing 101. In these figures, blood flow is shown in the downstream direction and indicated by “AA”. The trigger lever 126 is adjustable between a plurality of positions, each position moving the protrusion 128, which applies or releases pressure to/from the arterial tubing 101, to control lumen size/diameter. The lumen size/diameter corresponds to a rate of blood flow through the arterial tubing 101.


In FIG. 9A, the tab 109 of the engagement arm 108 of the trigger lever 126 is above the shoulder 120x of the trigger housing 103. The lumen 101c of the arterial tubing 101 is at its maximum diameter, as the trigger lever 126, via its protrusion 128 is not applying pressure on the arterial tubing 101. The inner diameter of the lumen 101c is Q1, which is equal to X.


In FIG. 9B, the tab 109 has been moved below the shoulder 120x, by a force, represented by the arrow M, which may be a manual force, such that the protrusion 128 impinges on outer surface 101b of arterial side tubing 101, causing the outer surface 101b to move inward, and for example deform the tube 101, such that the lumen becomes smaller. The diameter of the lumen 101c has been reduced, from “X” to “Q2”, such that the rate of blood flow is reduced.



FIG. 9C is a cross sectional view along line 9C-9C of FIG. 9B. In this figure, the distance “D” represents the outer diameter of arterial side tubing 101 located inside of trigger housing 103 where “E” represents the width of the bottom surface of the “U” shaped protuberance 128 of trigger lever 126. In some embodiments, length “E” is from 40% to 100% of distance “D”. As a result, blood flow (blood flow rate) is regulated by being slowed.


In FIG. 9D, the trigger lever 126 is fully depressed by force, represented by the arrow M (for example, a manual force), fully reducing the diameter of the lumen 101c from “X” to zero, closing or otherwise pinching off the arterial tubing 101. Blood flow through the arterial tubing 101 is now stopped.


Although the embodiments described herein mainly address blood transfer by shunting, the methods and systems described herein can also be used in other applications, such as in transfers of other bodily fluids, as well as fluid draining from the body, and fluid infusion into the body.


It will thus be appreciated that the embodiments described above are cited by way of example, and that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and sub-combinations of the various features described hereinabove, as well as variations and modifications thereof which would occur to persons skilled in the art upon reading the foregoing description and which are not disclosed in the prior art. Documents incorporated by reference in the present patent application are to be considered an integral part of the application except that to the extent any terms are defined in these incorporated documents in a manner that conflicts with the definitions made explicitly or implicitly in the present specification, only the definitions in the present specification should be considered.

Claims
  • 1. A shunt comprising: a first housing configured for receiving a first conduit for blood ingress, the first conduit for extending in the first housing;a regulator extending into the first housing for communicating with the first conduit to control blood flow rate through the first conduit;a second housing removably attachable from the first housing, the second housing comprising a cavity for receiving and holding blood from the first conduit, and configured for receiving a second conduit, such that the second conduit is in communication with the cavity for blood egress through the second conduit;a blood filter extending at least partially into the cavity of the second housing, the blood filter in the second housing for communication with the first conduit in the first housing; anda connector disc for seating in the first housing, the connector disc including oppositely disposed first and second sides, and including an aperture extending between the first and second sides, the connector disc for connecting with the first conduit one the first side, and the blood filter on the second side, whereby the first conduit communicates with the blood filter via the aperture to form a path for blood flow through the shunt.
  • 2. The shunt of claim 1, additionally comprising: a connector for joining the first housing to the second housing so that the second housing is removably attachable from the first housing.
  • 3. The shunt of claim 2, wherein the first housing and the connector form a threaded connection, such that the first housing and second housing are removably attachable from each other.
  • 4. The shunt of claim 1, wherein the regulator is adjustable between a plurality of positions, each position corresponding to a rate of blood flow through the first conduit.
  • 5. The shunt of claim 4, wherein the regulator includes a trigger lever, the trigger lever being movably mounted in the first housing.
  • 6. The shunt of claim 1, additionally comprising the first conduit extending through the first housing for blood ingress into the first housing.
  • 7. The shunt of claim 1, further comprising the second conduit in communication with the cavity for blood egress from the cavity of the second housing.
  • 8. The shunt of claim 1, wherein the connector disc includes a conduit connector extending from the first side in line with the aperture, for connecting with the first conduit in at least a friction fit, and, a plurality of outwardly extending and circumferentially arranged fingers about the aperture, such that the fingers for receiving the blood filter in at least a snap fit, whereby the first conduit, the conduit connector, the aperture and the blood filter are aligned to form the path for blood flow through the shunt.
  • 9. The shunt of claim 1 additionally comprising: a plurality of protrusions extending into an inner cavity of the first housing for receiving the connector disc to seat in the first housing, and when the first housing is removably attached to the second housing, the connector disc in held in the first housing by a press fit between the plurality of protrusions and a portion of the second housing which extends into the first housing.
  • 10. A method for assembling a medical device comprising: providing a shunt comprising: a first housing configured for receiving a first conduit for blood ingress;a regulator extending into the first housing for communicating with the first conduit to control blood flow rate through the first conduit; anda second housing removably attachable from the first housing, the second housing comprising a cavity for receiving and holding blood from the first conduit, and configured for receiving a second conduit;attaching a first conduit to the shunt at the first housing; andattaching a second conduit to the shunt at the second housing;whereby the first conduit and the second conduit are in communication with each other via the shunt,wherein the shunt further comprises: a blood filter extending at least partially into the cavity of the second housing, the blood filter in the second housing for communication with the first conduit in the first housing; anda connector disc for seating in the first housing, the connector disc including oppositely disposed first and second sides, and including an aperture extending between the first and second sides, the connector disc for connecting with the first conduit one the first side, and the blood filter on the second side, whereby the first conduit communicates with the blood filter via the aperture to form a path for blood flow through the shunt.
  • 11. A method for blood transfer in a mammalian patient comprising: providing a shunt comprising: a first housing configured for receiving a first conduit for blood ingress;a regulator extending into the first housing for communicating with the first conduit to control blood flow rate through the first conduit; anda second housing removably attachable from the first housing, the second housing comprising a cavity for receiving and holding blood from the first conduit, and configured for receiving a second conduit;attaching a first conduit to the shunt at the first housing;attaching a second conduit to the shunt at the second housing;placing the first conduit in communication with the mammalian patient at a first location on the mammalian patient; andplacing the second conduit in communication with the mammalian patient at a second location on the mammalian patent;such that a blood flow pathway is established between the first conduit and the second conduit, via the shunt,wherein the shunt further comprises: a blood filter extending at least partially into the cavity of the second housing, the blood filter in the second housing for communication with the first conduit in the first housing; anda connector disc for seating in the first housing, the connector disc including oppositely disposed first and second sides, and including an aperture extending between the first and second sides, the connector disc for connecting with the first conduit one the first side, and the blood filter on the second side, whereby the first conduit communicates with the blood filter via the aperture to form a path for blood flow through the shunt.
  • 12. The method of claim 11, wherein the first location comprises an arterial portion of a circulatory system of the mammalian patient, and the second location comprises a venous portion of the circulatory system of the mammalian patient, and the blood flow pathway is from the first conduit to the second conduit, via the shunt.
  • 13. The method of claim 12, additionally comprising: regulating the blood flow along the blood flow pathway by placing the regulator into contact with the first conduit at a location along the first conduit and depressing the regulator to cause the first conduit to decrease in size proximate to the location.
  • 14. The method of claim 12, additionally comprising: regulating the blood flow along the blood flow pathway by releasing the regulator from the depressing contact with the first conduit at the location along the first conduit, to cause the first conduit to increase in size proximate to the location.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is related to and claims priority from commonly owned U.S. Provisional Patent Application, Ser. No. 63/165,856, entitled: Device For Shunting Blood Between The Arterial And Venous Systems Of A Patient, filed on Mar. 25, 2021, the disclosure of which is incorporated by reference in its entirety herein.

PCT Information
Filing Document Filing Date Country Kind
PCT/IB2022/052688 3/24/2022 WO
Publishing Document Publishing Date Country Kind
WO2022/201081 9/29/2022 WO A
US Referenced Citations (150)
Number Name Date Kind
3641994 Gosling et al. Feb 1972 A
4559034 Kirita et al. Dec 1985 A
4661097 Fischell et al. Apr 1987 A
4874359 White et al. Oct 1989 A
5374239 Mischenko Dec 1994 A
5395105 Thommen, Jr. Mar 1995 A
5601572 Middleman et al. Feb 1997 A
5843244 Pelton et al. Dec 1998 A
5954691 Prosl Sep 1999 A
6019772 Shefaram et al. Feb 2000 A
6019778 Wilson et al. Feb 2000 A
6071269 Schnell et al. Jun 2000 A
6109406 Takagi et al. Aug 2000 A
6129755 Mathis et al. Oct 2000 A
6206868 Parodi Mar 2001 B1
6235042 Katzman May 2001 B1
6295989 Connors, III Oct 2001 B1
6312454 Stoeckel et al. Nov 2001 B1
6312455 Duerig et al. Nov 2001 B2
6413235 Parodi Jul 2002 B1
6423032 Parodi Jul 2002 B2
6425898 Wilson et al. Jul 2002 B1
6503271 Duerig et al. Jan 2003 B2
6540712 Parodi et al. Apr 2003 B1
6582396 Parodi Jun 2003 B1
6632236 Hogendijk Oct 2003 B2
6641573 Parodi Nov 2003 B1
6645222 Parodi et al. Nov 2003 B1
6682505 Bates et al. Jan 2004 B2
6689084 Kaganov et al. Feb 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6773446 Dwyer et al. Aug 2004 B1
6859986 Jackson et al. Mar 2005 B2
6863685 Davila et al. Mar 2005 B2
6905490 Parodi Jun 2005 B2
6908474 Hogendijk et al. Jun 2005 B2
6935404 Duerig et al. Aug 2005 B2
6936060 Hogendijk et al. Aug 2005 B2
6942688 Bartholf et al. Sep 2005 B2
7063685 Rome Jun 2006 B2
7344527 Schweikert Mar 2008 B2
7879011 Chang Feb 2011 B2
7927347 Hogendijk et al. Apr 2011 B2
7998104 Chang Aug 2011 B2
8002728 Chang Aug 2011 B2
8157760 Criado et al. Apr 2012 B2
8235943 Breznock et al. Aug 2012 B2
8308709 Chang Nov 2012 B2
8343089 Chang Jan 2013 B2
8414516 Chang Apr 2013 B2
8444586 Beck May 2013 B2
8545432 Renati et al. Oct 2013 B2
8545552 Garrison et al. Oct 2013 B2
8574245 Garrison et al. Nov 2013 B2
8740834 Criado et al. Jun 2014 B2
8784355 Criado et al. Jul 2014 B2
8858490 Chou et al. Oct 2014 B2
8870805 Chang Oct 2014 B2
9011364 Criado et al. Apr 2015 B2
9011467 Garrison et al. Apr 2015 B2
9084857 Cully et al. Jul 2015 B2
9126018 Garrison Sep 2015 B1
9138527 Renati et al. Sep 2015 B2
9179909 Garrison et al. Nov 2015 B2
9241699 Kume et al. Jan 2016 B1
9259215 Chou et al. Feb 2016 B2
9265512 Garrison et al. Feb 2016 B2
9295817 Chang Mar 2016 B2
9399118 Kume et al. Jul 2016 B2
9427305 Kuraguntla et al. Aug 2016 B2
9492637 Garrison et al. Nov 2016 B2
9526504 Chang Dec 2016 B2
9561345 Garrison et al. Feb 2017 B2
9623228 Ryan et al. Apr 2017 B2
9655755 Chou et al. May 2017 B2
9662118 Chang May 2017 B2
9662480 Kume et al. May 2017 B2
9668743 Cully et al. Jun 2017 B2
9669183 Chang Jun 2017 B2
9669191 Chou et al. Jun 2017 B2
9693789 Garrison et al. Jul 2017 B2
9789242 Criado et al. Oct 2017 B2
9820761 Garrison et al. Nov 2017 B2
9833555 Criado et al. Dec 2017 B2
9861783 Garrison et al. Jan 2018 B2
10039906 Kume et al. Aug 2018 B2
10085864 Chou et al. Oct 2018 B2
10159479 Hentges et al. Dec 2018 B2
10182801 Garrison Jan 2019 B2
10188399 Chang Jan 2019 B2
10226563 Garrison et al. Mar 2019 B2
10226598 Chou et al. Mar 2019 B2
10238853 Kume Mar 2019 B2
10272269 Garrison et al. Apr 2019 B2
10286139 Criado et al. May 2019 B2
10327790 Garrison et al. Jun 2019 B2
10328232 Chang Jun 2019 B2
10357242 Garrison et al. Jul 2019 B2
10369346 Ryan et al. Aug 2019 B2
10384034 Garrison et al. Aug 2019 B2
10390847 Garrison et al. Aug 2019 B2
10426497 Chou et al. Oct 2019 B2
10426885 Criado et al. Oct 2019 B2
10485917 Criado et al. Nov 2019 B2
10543307 Criado et al. Jan 2020 B2
10709832 Criado et al. Jul 2020 B2
10722239 Chang Jul 2020 B2
10779835 Chang Sep 2020 B2
10779855 Garrison Sep 2020 B2
10799244 Cully et al. Oct 2020 B2
10799669 Chou et al. Oct 2020 B2
10828460 Chang Nov 2020 B2
10864357 Kume et al. Dec 2020 B2
10881393 Hentges et al. Jan 2021 B2
10918504 Wallace et al. Feb 2021 B2
10925709 Rogers et al. Feb 2021 B2
10939929 Garrison et al. Mar 2021 B2
10952882 Chou et al. Mar 2021 B2
10973502 Garrison Apr 2021 B2
11020133 Wilson et al. Jun 2021 B2
11027104 Kume et al. Jun 2021 B2
11097132 Garrison et al. Aug 2021 B2
11103627 Garrison et al. Aug 2021 B2
11141259 MacDonald et al. Oct 2021 B2
20010047184 Connors, III Nov 2001 A1
20020087119 Parodi Jul 2002 A1
20070055296 Stergiopulos Mar 2007 A1
20100168682 Braga et al. Jul 2010 A1
20100198158 Loewen Aug 2010 A1
20100204684 Garrison et al. Aug 2010 A1
20110098649 Nardeo et al. Apr 2011 A1
20110284776 Gay et al. Nov 2011 A1
20130041305 Tarlian, Jr. et al. Feb 2013 A1
20130317409 Cully et al. Nov 2013 A1
20140088482 Schlaeper et al. Mar 2014 A1
20140221932 Puhasmagi et al. Aug 2014 A1
20140243759 Yoon et al. Aug 2014 A1
20140296769 Hyde et al. Oct 2014 A1
20140303427 Kerkhoffs et al. Oct 2014 A1
20160242764 Garrison et al. Aug 2016 A1
20190344058 Hakim Nov 2019 A1
20190351182 Chou et al. Nov 2019 A1
20190358443 Lopez Nov 2019 A1
20200289039 Bullington et al. Sep 2020 A1
20200289794 Fantuzzi Sep 2020 A1
20200292367 Elizalde Sep 2020 A1
20200397472 MacDonald et al. Dec 2020 A1
20210145453 Kume May 2021 A1
20210298929 Wallace et al. Sep 2021 A1
20220226556 Drake Jul 2022 A1
Foreign Referenced Citations (30)
Number Date Country
100534392 Sep 2009 CN
204709643 Oct 2015 CN
209848141 Dec 2019 CN
2497520 Sep 2012 EP
1356836 Nov 2013 EP
2019154669 Sep 2019 JP
1951362 Mar 2010 PT
2004011058 Feb 2004 WO
2005051206 Jun 2005 WO
2009012473 Jan 2009 WO
2009100210 Aug 2009 WO
2010075445 Jul 2010 WO
2013008168 Jan 2013 WO
2013022796 Feb 2013 WO
2013036193 Mar 2013 WO
2013130258 Sep 2013 WO
2013181352 Dec 2013 WO
2015100178 Jul 2015 WO
2016018781 Feb 2016 WO
2016036660 Mar 2016 WO
2016164606 Oct 2016 WO
2016176409 Nov 2016 WO
2018017981 Jan 2018 WO
2018156574 Aug 2018 WO
2019010077 Jan 2019 WO
2019055487 Mar 2019 WO
2019183189 Sep 2019 WO
2021087363 May 2021 WO
2021087480 May 2021 WO
2022201081 Sep 2022 WO
Non-Patent Literature Citations (26)
Entry
U.S. Appl. No. 17/576,953 Office Action dated Jul. 20, 2023.
Saint-Gobain Performance Plastics Corporation, “TYGON Medical/Surgical Tubing S-50-HL,” pp. 1-2, year 2004.
Silk Road Medical Inc., “Enhance Transcarotid Peripheral Access Kit,” pp. 1-2, Dec. 28, 2018.
Silk Road Medical Inc., “Enroute Transcarotid Stent System,” pp. 1-4, May 27, 2021.
International Applicaton # PCT/IB2022/052688 Search Report dated Jul. 7, 2022.
Schreck, U.S. Appl. No. 17/889,423, filed Aug. 17, 2022.
Sherif, “Homemade TCAR with Flow Reversal for Primary Proximal Carotid Artery Aneurisms in a Patent with Crescendo TIAS post neck operation,” Linkedin post, pp. 1-2, year 2021, as downloaded from https://www.linkedin.com/posts/profsherifsultan_nuig-tcar-cast-activity-6710036851517902848-Qwzw.
Silk Road Medical, Inc., “Enroute Transcarotid Neuroprotection System”, Manual, pp. 1-20, Mar. 7, 2020, year 2022, as downloaded from file:///C:/Users/Miriam/Downloads/_https_silkroadmed.com_wp-content_uploads_2020_09_11858.7-ENROUTE-NPS-IFU-US-ARTWORK1%20(1).pdf.
Parodi et al., “Cerebral Protection During Carotid Stenting Using Flow Reversal,” Journal of Vascular Surgery, vol. 41, No. 3, pp. 416-422, year 2005.
Perez-Grueso et al., “Angioplastia y Stenting Carotideo por Miniacceso Cervical y Flujo Invertido,” Angiologia, vol. 56, supl. 1, pp. S225-234, year 2004.
Luk et al., “Transcarotid Artery Revascularization as a New Modality of Treatment for Carotid Stenosis,” Journal Pre-proof, Annals of Vascular Surgery, Elsevier Inc., pp. 1-14, year 2019.
Chang et al., “A New Approach to Carotid Angioplasty and Stenting with Transcervical Occlusion and Protective Shunting: Why it May be a Better Carotid Artery Intervention,” Journal of Vascular Surgery, vol. 39, No. 5, pp. 994-1002, May 2004.
Lin et al., “Protected Carotid Artery Stenting and Angioplasty via Transfemoral versus Transcervical Approaches,” Vascular and Endovascular Surgery, vol. 39, No. 6, pp. 499-503, year 2005.
Silk Road Medical, “TransCarotid Artery Revascularization (TCAR),” Product Overview, pp. 1-6, year 2022, as downloaded from https://silkroadmed.com/patient-caregivers/the-tcar-procedure/.
Rhodes et al., “Arteriovenous Shunt Measurements in Extremities,” Journal of Nuclear Medicine, vol. 13, No. 6, pp. 357-362, year 1972.
“Qosina—Medical Device Components/OEM Components,” product catalogue, Qosina Corp., USA, Qosina Europe Srl., Italy, pp. 1-4, year 2022, as downloaded from https://www.qosina.com/.
Sherif, “The TCAR Procedure: Transcervical carotid Artery Revascularization and stenting by C-Guard”, Linkedin post, p. 1-1, year 2021, as downloaded from https://www.linkedin.com/feed/update/urn:li:activity:6689646427859140608/.
Drake et al., U.S. Appl. No. 63/211,025, filed Jun. 16, 2021.
Inspiremd, “Sustained Embolic Protection”, pp. 1-23, Jul. 8, 2020, as downloaded from https://www.inspiremd.com/en/wp-content/uploads/InspireMD-Investor-Deck-Revised-July-8-2020_compressed.pdf.
JP Application # 2023542563 Office Action dated Nov. 21, 2023.
International Application PCT/IB2023/057821 Search report dated Dec. 31, 2023.
CN Application # 2022800098002 Office Action dated Feb. 23, 2024.
JP Applicaton # 2023549856 Office Action dated Mar. 14, 2024.
EP Application # 22739245.3 Search Report dated Apr. 9, 2024.
CN Application # 2022800089963 Office Action dated Apr. 10, 2024.
EP Application # 22774473.7 Search Report dated Jun. 6, 2024.
Related Publications (1)
Number Date Country
20240033412 A1 Feb 2024 US
Provisional Applications (1)
Number Date Country
63165856 Mar 2021 US